ZFIN ID: ZDB-FISH-150901-12774
Fish name: WT + MO1-tbx5a
Genotype: WT
Targeting Reagent: MO1-tbx5a
HUMAN DISEASE MODELED by WT + MO1-tbx5a
Human Disease Conditions Citations
Holt-Oram syndrome standard conditions Garrity et al., 2002
GENE EXPRESSION
Gene expression in WT + MO1-tbx5a
RNA expression
Expressed Gene Structure Conditions Figures
akt2 standard conditions Fig. 2 with image from Tsai et al., 2012
badb chemical treatment by injection: growth hormone Fig. 4 with image from Tsai et al., 2012
standard conditions Fig. 4 with image from Tsai et al., 2012
Fig. 2 with image from Lu et al., 2011
baxa standard conditions Fig. 2 with image from Lu et al., 2011
bcl2a chemical treatment by injection: growth hormone Fig. 4 with image from Tsai et al., 2012
standard conditions Fig. 4 with image from Tsai et al., 2012
Fig. 2 with image from Lu et al., 2011
casp8 standard conditions Fig. 4 with image from Lu et al., 2011
cdk2 standard conditions Fig. 5 with image from Tsai et al., 2012
chemical treatment by injection: growth hormone Fig. 5 with image from Tsai et al., 2012
cdkn1bb standard conditions Fig. 5 with image from Tsai et al., 2012
chemical treatment by injection: growth hormone Fig. 5 with image from Tsai et al., 2012
efnb2a standard conditions Fig. 4 with image from Pi-Roig et al., 2014
ephb2a standard conditions Fig. 4 with image from Pi-Roig et al., 2014
fgf24 standard conditions Fig. 6 with image from Fischer et al., 2003
ghra standard conditions Fig. 2 with image from Tsai et al., 2012
ghrb standard conditions Fig. 2 with image from Tsai et al., 2012
hand2 standard conditions Fig. 6 from Lu et al., 2008
has2 standard conditions Fig. 4 from Tong et al., 2014
igf1 standard conditions Fig. 2 with image from Tsai et al., 2012
Fig. 6 from Lu et al., 2008
mstnb standard conditions Fig. 6 from Lu et al., 2008
myh6 chemical treatment by injection: growth hormone Fig. 6 with image from Tsai et al., 2012
standard conditions Fig. 6 with image from Tsai et al., 2012
Fig. 5,  Fig. 6 from Lu et al., 2008
myh7 chemical treatment by injection: growth hormone Fig. 6 with image from Tsai et al., 2012
standard conditions Fig. 6 with image from Tsai et al., 2012
Fig. 5,  Fig. 6 from Lu et al., 2008
myl7 chemical treatment by injection: growth hormone Fig. 6 with image from Tsai et al., 2012
standard conditions Fig. 2 with image from Pi-Roig et al., 2014
Fig. 6 with image from Tsai et al., 2012
Fig. 1 with image from Lou et al., 2011
Fig. 5,  Fig. 6 from Lu et al., 2008
myod1 standard conditions Fig. 6 from Lu et al., 2008
ndrg4 standard conditions Fig. 9 with image from Qu et al., 2008
nkx2.5 standard conditions Fig. 1 with image from Lou et al., 2011
Fig. 6 from Lu et al., 2008
prdm1a standard conditions Fig. 5 with image from Lee et al., 2006
sall1a standard conditions Fig. 4 with image from Harvey et al., 2006
sall4 standard conditions Fig. 2 with image from Harvey et al., 2006
tbx5a standard conditions Fig. 6 from Lu et al., 2008
Fig. 2 with image from Harvey et al., 2006
Reporter gene expression No data available
PHENOTYPE
Phenotype in WT + MO1-tbx5a
Phenotype Conditions Figures
apoptotic process increased occurrence, abnormal standard conditions Fig. 3 with image from Tsai et al., 2012
Fig. 1 with image from Lu et al., 2011
apoptotic process occurrence, ameliorated chemical treatment by injection: growth hormone Fig. 3 with image from Tsai et al., 2012
atrium myh6 expression amount, ameliorated chemical treatment by injection: growth hormone Fig. 6 with image from Tsai et al., 2012
atrium myh6 expression decreased amount, abnormal standard conditions Fig. 6 with image from Tsai et al., 2012
atrium morphology, abnormal standard conditions Fig. 4 from Ghosh et al., 2017
atrium size, abnormal standard conditions Fig. 4 from Ghosh et al., 2017
cardiac muscle cell normal amount, normal standard conditions Fig. 1 with image from Lou et al., 2011
cardiac muscle cell bicellular tight junction dissociated from cardiac muscle cell bicellular tight junction, abnormal standard conditions Fig. 7 with image from Lu et al., 2011
cardiac muscle cell mitochondrion increased amount, abnormal standard conditions Fig. 7 with image from Lu et al., 2011
cardiac muscle cell mitochondrion swollen, abnormal standard conditions Fig. 7 with image from Lu et al., 2011
cardiac ventricle myh7 expression amount, ameliorated chemical treatment by injection: growth hormone Fig. 6 with image from Tsai et al., 2012
cardiac ventricle myl7 expression amount, ameliorated chemical treatment by injection: growth hormone Fig. 6 with image from Tsai et al., 2012
cardiac ventricle myh7 expression decreased amount, abnormal standard conditions Fig. 6 with image from Tsai et al., 2012
cardiac ventricle myl7 expression decreased amount, abnormal standard conditions Fig. 6 with image from Tsai et al., 2012
cardiac ventricle decreased contractility, abnormal standard conditions Fig. 1 with image from Tsai et al., 2012
cardiac ventricle morphology, abnormal standard conditions Fig. 4 from Ghosh et al., 2017
cardiac ventricle size, abnormal standard conditions Fig. 4 from Ghosh et al., 2017
heart decreased size, abnormal standard conditions Fig. 2 from Lu et al., 2008
heart edematous, abnormal standard conditions Fig. 1 with image from Tsai et al., 2012
heart malformed, abnormal standard conditions Fig. 1 with image from Pi-Roig et al., 2014
Fig. 1 with image from Lu et al., 2011
heart morphology, abnormal standard conditions Fig. 4 from Ghosh et al., 2017
Fig. 6 from Li et al., 2014
Fig. 1 with image from Tsai et al., 2012
Fig. 1,  Fig. 2,  Fig. 5 from Lu et al., 2008
Fig. 9 with image from Qu et al., 2008
heart morphology, ameliorated chemical treatment by injection: growth hormone Fig. 6 from Li et al., 2014
heart morphology, normal standard conditions Fig. 1 with image from Lou et al., 2011
heart contraction decreased rate, abnormal standard conditions Fig. 4 from Ghosh et al., 2017
heart development disrupted, abnormal standard conditions Fig. 9 with image from Qu et al., 2008
heart jogging disrupted, abnormal standard conditions Fig. 2 with image from Pi-Roig et al., 2014
heart looping arrested, abnormal standard conditions Fig. 1 with image from Pi-Roig et al., 2014
Fig. 4 with image from Garrity et al., 2002
heart looping disrupted, abnormal standard conditions Fig. 1 with image from Pi-Roig et al., 2014
Fig. 1 with image from Lu et al., 2011
Fig. 6 from Ghosh et al., 2009
Fig. 1,  Fig. 2,  Fig. 5 from Lu et al., 2008
heart looping process quality, abnormal standard conditions Fig. 4 from Ghosh et al., 2017
heart morphogenesis process quality, normal standard conditions Fig. 1 with image from Lou et al., 2011
heart tube linear, abnormal standard conditions Fig. 4 with image from Garrity et al., 2002
myocardium disorganized, abnormal standard conditions Fig. 7 with image from Lu et al., 2011
myocardium myofibril disorganized, abnormal standard conditions Fig. 7 with image from Lu et al., 2011
paired fin absent, abnormal standard conditions Fig. 6 from Ghosh et al., 2017
paired fin decreased size, abnormal standard conditions Fig. 6 from Ghosh et al., 2017
paired fin morphology, abnormal standard conditions Fig. 6 from Ghosh et al., 2017
pectoral fin absent, abnormal standard conditions Fig. 4 with image from Garrity et al., 2002
pectoral fin aplastic, abnormal standard conditions Fig. 5 with image from Pi-Roig et al., 2014
Fig. 1 with image from Tsai et al., 2012
Fig. 6 from Ghosh et al., 2009
pectoral fin hypoplastic, abnormal standard conditions Fig. 1 with image from Lu et al., 2011
pectoral fin morphology, abnormal standard conditions Fig. 6 from Li et al., 2014
pectoral fin morphology, ameliorated chemical treatment by injection: growth hormone Fig. 6 from Li et al., 2014
pectoral fin truncated, abnormal standard conditions Fig. 1 with image from Tsai et al., 2012
pectoral fin upturned, abnormal standard conditions Fig. 4 with image from Garrity et al., 2002
pectoral fin bud absent, abnormal standard conditions Fig. 6 with image from Fischer et al., 2003
pectoral fin development disrupted, abnormal standard conditions Fig. 5 with image from Pi-Roig et al., 2014
pericardium edematous, abnormal standard conditions Fig. 4 from Ghosh et al., 2017
Fig. 6 from Ghosh et al., 2009
Fig. 1,  Fig. 2 from Lu et al., 2008
somite shape, ameliorated chemical treatment by injection: growth hormone Fig. 6 from Li et al., 2014
somite U-shaped, abnormal standard conditions Fig. 6 from Li et al., 2014
Fig. 1 with image from Tsai et al., 2012
trunk bent, abnormal standard conditions Fig. 1 with image from Tsai et al., 2012
trunk curled, abnormal standard conditions Fig. 1 with image from Lu et al., 2011
trunk decreased length, abnormal standard conditions Fig. 1 with image from Lu et al., 2011
whole organism cdk2 expression amount, ameliorated chemical treatment by injection: growth hormone Fig. 5 with image from Tsai et al., 2012
whole organism badb expression amount, ameliorated chemical treatment by injection: growth hormone Fig. 4 with image from Tsai et al., 2012
whole organism cdkn1bb expression amount, ameliorated chemical treatment by injection: growth hormone Fig. 5 with image from Tsai et al., 2012
whole organism bcl2a expression amount, ameliorated chemical treatment by injection: growth hormone Fig. 4 with image from Tsai et al., 2012
whole organism ghrb expression decreased amount, abnormal standard conditions Fig. 2 with image from Tsai et al., 2012
whole organism akt2 expression decreased amount, abnormal standard conditions Fig. 2 with image from Tsai et al., 2012
whole organism ghra expression decreased amount, abnormal standard conditions Fig. 2 with image from Tsai et al., 2012
whole organism igf1 expression decreased amount, abnormal standard conditions Fig. 2 with image from Tsai et al., 2012
whole organism cdk2 expression increased amount, abnormal standard conditions Fig. 5 with image from Tsai et al., 2012
whole organism bcl2a expression increased amount, abnormal standard conditions Fig. 4 with image from Tsai et al., 2012
whole organism cdkn1bb expression increased amount, abnormal standard conditions Fig. 5 with image from Tsai et al., 2012
whole organism badb expression increased amount, abnormal standard conditions Fig. 4 with image from Tsai et al., 2012
whole organism lacks parts or has fewer parts of type pectoral fin, abnormal standard conditions Fig. 4 with image from Garrity et al., 2002
whole organism semi-lethal (sensu genetics), abnormal standard conditions Fig. 2 from Lu et al., 2008

CITATIONS  (15)

Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.